GTR Home > Tests > Search results - C1846343[DISCUI]

Apply filters

Showing tests for all 1152 conditions

Compare labs

Your search term can be found in tests with a total of 1152 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1846343[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 20 tests for 1152 conditions in 14 labs

CBartter syndrome type 3

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNuclear Genes involved with Mitochondrial Function (mito-exome)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Total conditions (583)
Total targets (416)

CepiSEEK® Comprehensive Sequence Analysis for Epilepsy and Seizure Disorders (489 genes)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (621)
Total targets (421)

CHereditary Renal Tubular Disorders Evaluation

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)
Total targets (5)

CCLCNKB DNA Sequencing Test

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCLCNKB. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CEpilepsy Advanced Sequencing Evaluation - Syndromic Disorders

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Methods
  • C Sequence analysis of the entire coding region
Total conditions (26)
Total targets (26)

CEpilepsy Advanced Sequencing Evaluation

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Total conditions (143)
Total targets (141)

CNuclear-Mito 500 NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (600)
Total targets (500)

CEpilepsy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (599)
Total targets (342)

CBartter Syndrome type 3 (sequence analysis of CLCNKB gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CBartter Syndrome Type 3

Lab: Bioscientia GmbH Center for Human Genetics Ingelheim, Rheinland-Pfalz, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CBartter Syndrome Type 3

Lab: Labor-MVZ Westmecklenburg Laboratory for Molecular Diagnostics Schwerin, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CBartter Syndrome Type 3

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CBartter Syndrome Type 3, CLCNKB

Lab: GGA - Galil Genetic Analysis Kazerin, HaZafon, Israel
Test targets
Methods
  • C Sequence analysis of the entire coding region

CBartter syndrome, type 3

Test targets
Methods
  • C Sequence analysis of the entire coding region

CTest for Bartter Syndrome Type 3

Lab: ProntoLab - MLPA Lab Pronto Diagnostics Ltd. Tel Aviv, Tel Aviv, Israel
Test targets
Methods
  • C Sequence analysis of the entire coding region

CTest for Bartter Syndrome Type 3

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • D Deletion/duplication analysis

CTest for Bartter Syndrome Type 3

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • D Deletion/duplication analysis

Showing 1 to 20 of 20 tests for 1152 conditions in 14 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk